• International mentorship is win-win for cancer researchers in U.S. and China

    A global problem is now being tackled globally by a unique relationship between Shanghai, China and the University of Colorado Cancer Center.

  • Smoking Cessation at University of Colorado Hospital

    NCI funds smoking cessation initiative at CU Cancer Center

    University of Colorado Cancer Center is one of 22 centers nationally to receive funding through NCI Cancer Center Cessation Initiative to define best practices for smoking cessation in cancer patients.

  • Study finds a new way to shut down cancer cells’ ability to consume glucose

    Many cancers depend on glucose consumption for energy, but good pharmacological targets to stop cancers’ ability to uptake and metabolize glucose are missing. CU Cancer Center study finally identifies a way to restrict the ability of cancer to use glucose for energy.

  • Important new insights into RECIST criteria measuring cancer’s response to treatment

    CU Cancer Center article examines current RECIST guidelines in an effort to bring them up to speed with new complexities presented by the latest targeted therapies.

  • In the lab and in the clinic, alisertib with TAK-228 excels against solid tumors, including triple-negative breast cancer

    Two CU Cancer Center studies presented this weekend at AACR Molecular Targets and Cancer Therapeutics Meeting show that using the drug alisertib along with the drug TAK-228 is more effective against triple-negative breast cancer and solid tumors than either drug alone.

Patient Care

“Nothing more I can ask for” – Personalized medicine ensures mom will see her kids grow up

For Sarah McRorie, the time after the birth of her daughter Sloane brought hugs, kisses, new challenges…

Read the rest of this entry

colon cancer cu cancer center

Research

Meet the Experts

A CONVERSATION WITH ROBERT GARCEA, MD

Cervical cancer is directly related to prior infection with human papillomavirus (HPV). Primarily due to PAP…

Read the rest of this entry